Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐ STIM study

Dulucq, Stéphanie, Rigal‐Huguet, Françoise, Nicolini, Franck E. · British Journal of Haematology · 2023